# Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population

> **NCT03696940** · PHASE3 · UNKNOWN · sponsor: **Laboratorios Grossman, S.A.** · enrollment: 120 (actual)

## Conditions studied

- Dyslipidemias
- Cardiovascular Risk Factor

## Interventions

- **DRUG:** L-Carnitine 500Mg Oral Tablet + Atorvastatin 10 mg
- **DRUG:** Atorvastatin 10mg

## Key facts

- **NCT ID:** NCT03696940
- **Lead sponsor:** Laboratorios Grossman, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-28
- **Primary completion:** 2019-03-01
- **Final completion:** 2019-08-31
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03696940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03696940, "Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03696940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*